You are here

Our science / Clinical Trials / Find a Trial / NCT00238719

Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder

Back to Search Print Save as PDF Bookmark Trial

NCT00238719

Last updated on March 15, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Social Anxiety Disorder
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
8-17 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male or female outpatient

- 8-17 year old

- diagnosis of Social Anxiety Disorder

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- concomitant psychiatric or medical disorders which interfere with safety or assessment

NCT00238719
Pfizer
Completed
Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Social Anxiety Disorder
Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder
NCT00238719
All Genders

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now